Haemophilia

Cover image for Vol. 23 Issue 1

Early View (Online Version of Record published before inclusion in an issue)

Co-Editors C. Kessler and M. Makris

Impact Factor: 2.673

ISI Journal Citation Reports © Ranking: 2015: 35/70 (Hematology)

Online ISSN: 1365-2516

VIEW

  1. 1 - 25
  1. Original Articles

    1. Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficency

      G. N. Pike, A. M. Cumming, J. Thachil, C. R. M. Hay, P. H. B. Bolton-Maggs and J. Burthem

      Version of Record online: 16 JAN 2017 | DOI: 10.1111/hae.13136

  2. Letters to the Editor

    1. VWF collagen (types III and VI)-binding defects in a cohort of type 2M VWD patients – a strategy for improvement of a challenging diagnosis

      T. Fidalgo, A. Oliveira, C. Silva Pinto, P. Martinho, G. Ferreira, R. Salvado, T. Sevivas, C. Catarino and M. L. Ribeiro

      Version of Record online: 12 JAN 2017 | DOI: 10.1111/hae.13156

  3. Original Articles

    1. You have full text access to this OnlineOpen article
      Measurement properties of the Haem-A-QoL in haemophilia clinical trials

      S. von Mackensen, A. Eldar-Lissai, P. Auguste, S. Krishnan, R. von Maltzahn, R. Yu and K. W. Wyrwich

      Version of Record online: 27 DEC 2016 | DOI: 10.1111/hae.13140

    2. You have full text access to this OnlineOpen article
      Efficacy and safety of a VWF/FVIII concentrate (wilate®) in inherited von Willebrand disease patients undergoing surgical procedures

      A. Srivastava, M. Serban, S. Werner, B. A. Schwartz, C. M. Kessler and For the Wonders Study Investigators

      Version of Record online: 27 DEC 2016 | DOI: 10.1111/hae.13106

    3. You have full text access to this OnlineOpen article
  4. Letters to the Editor

    1. Splice site mutation in factor X gene manifesting as severe intracranial haemorrhage in neonatal period with a challenging treatment course

      P. P. Madhusoodhan, B. Y. Lu, J. Chen, C. L. Jones, J. A. Meyer, E. A. Roman, M. Nardi, W. L. Carroll and T. Bhatla

      Version of Record online: 19 DEC 2016 | DOI: 10.1111/hae.13138

  5. Review Articles

    1. You have full text access to this OnlineOpen article
      BAY 81-8973, a full-length recombinant factor VIII: manufacturing processes and product characteristics

      S. Garger, J. Severs, L. Regan, A. Hesslein, J. Ignowski, P. Wu, E. Long, S. Gupta, S. Liu and W. Wang

      Version of Record online: 19 DEC 2016 | DOI: 10.1111/hae.13148

  6. Letters to the Editor

    1. Plasma products do not solve the inhibitor problem

      H. M. van den Berg, S. Pipe and R. Ljung

      Version of Record online: 19 DEC 2016 | DOI: 10.1111/hae.13132

  7. Original Articles

    1. Interventional therapies and in-hospital outcomes in acute coronary syndromes complicated by von Willebrand disease

      P. F. Fogarty, A. Blair, R. Vega, W. H. Matthai and P. A. Gimotty

      Version of Record online: 14 DEC 2016 | DOI: 10.1111/hae.13149

    2. Usefulness of a simple self-administered joint condition assessment sheet to predict the need for orthopaedic intervention in the management of haemophilic arthropathy

      T. Masaoka, K. Amano, H. Takedani, T. Suzuki, M. Otaki, I. Seita, T. Tateiwa, T. Shishido, K. Yamamoto and K. Fukutake

      Version of Record online: 11 DEC 2016 | DOI: 10.1111/hae.13135

  8. Letters to the Editor

    1. Transmission of severe haemophilia A by in vitro fertilization with donated eggs

      C. Sweeney, L. Khalil and N. Curry

      Version of Record online: 11 DEC 2016 | DOI: 10.1111/hae.13124

  9. Original Articles

    1. F376A/M388A-solulin, a new promising antifibrinolytic for severe haemophilia A

      J. Parcq, K. U. Petersen, A. Borel-Derlon, P. Gautier, M. Ebel, D. Vivien and Y. Repessé

      Version of Record online: 8 DEC 2016 | DOI: 10.1111/hae.13126

  10. Letters to the Editor

    1. Do the SIPPET study results apply to the patients I treat?

      K. Fischer and J. Blatny

      Version of Record online: 8 DEC 2016 | DOI: 10.1111/hae.13133

  11. Original Articles

    1. You have full text access to this OnlineOpen article
      Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A

      E. S. Mullins, O. Stasyshyn, M. T. Alvarez-Román, D. Osman, R. Liesner, W. Engl, M. Sharkhawy and B. E. Abbuehl

      Version of Record online: 27 NOV 2016 | DOI: 10.1111/hae.13119

    2. Joint lavage followed by viscosupplementation and triamcinolone in patients with severe haemophilic arthropathy: objective functional results

      M. U. Rezende, F. R. Andrusaitis, R. T. Silva, E. Okazaki, J. D. A. Carneiro, G. C. Campos, A. F. Pailo, R. Frucchi, T. Pasqualin and P. R. Villaça

      Version of Record online: 16 NOV 2016 | DOI: 10.1111/hae.13115

    3. Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics

      J. Kahle, A. Orlowski, D. Stichel, J. F. Healey, E. T. Parker, S. M. Donfield, J. Astermark, E. Berntorp, P. Lollar, D. Schwabe and C. Königs

      Version of Record online: 8 NOV 2016 | DOI: 10.1111/hae.13105

    4. Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency

      G. N. Pike, A. M. Cumming, J. Thachil, C. R. M. Hay, J. Burthem and P. H. B. Bolton-Maggs

      Version of Record online: 8 NOV 2016 | DOI: 10.1111/hae.13112

    5. Bleeding and liver transplantation outcomes in haemophilia

      K. D. Mehta and M. V. Ragni

      Version of Record online: 4 NOV 2016 | DOI: 10.1111/hae.13104

    6. Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System

      R. Kulkarni, R. J. Presley, J. M. Lusher, A. D. Shapiro, J. C. Gill, M. Manco-Johnson, M. A. Koerper, T. C. Abshire, D. DiMichele, W. K. Hoots, P. Mathew, D. J. Nugent, S. Geraghty, B. L. Evatt and J. M. Soucie

      Version of Record online: 4 NOV 2016 | DOI: 10.1111/hae.13081

    7. A prospective diagnostic accuracy study evaluating rotational thromboelastometry and thromboelastography in 100 patients with von Willebrand disease

      D. E. Schmidt, A. Majeed, M. Bruzelius, J. Odeberg, M. Holmström and A. Ågren

      Version of Record online: 26 OCT 2016 | DOI: 10.1111/hae.13121

    8. Retrospective analysis of in vivo recovery and clearance during continuous infusion of recombinant factor VIII products: a single-institution study

      N. Suzuki, A. Hirakawa, M. Kishimoto, T. Kanematsu, M. Ogawa, H. Kiyoi and T. Matsushita

      Version of Record online: 5 OCT 2016 | DOI: 10.1111/hae.13082

VIEW

  1. 1 - 25

SEARCH

SEARCH BY CITATION